We adapted the ultracentrifugation method of the Lipid Research Clinics Program for the separation of lipid subfractions (LDL, VLDL and HDL cholesterol) to a tabletop ultracentrifuge (Beckman TL-IOO). Centrifugation time was reduced from 18 h to 2·5 h and the sample volume from 5 mL to 2 mL plasma. The imprecision of the LDL-cholesterol estimation (coefficient of variation = CV) was 2,9-7,4% and that of HDL-cholesterol measurement was 1-4-3'9%. Imprecision of the VLDL-C measurement was high (CV = 15'6-29,8%). The results correlated with those obtained by the Lipid Research Clinics method (P < 0·00 I). Our method could be conveniently adapted by clinical laboratories serving specialist lipid clinics.
The relationship between elevated cholesterol and low density lipoprotein (LDL) concentrations and coronary heart disease (CHD) is well established. 1 -J LDL is considered to be the most atherogenic lipoprotein particle and its estimation permits a more reliable assessment of CHD risk than the measurement of total cholestrol.v"? The US National Cholesterol Education Program recommended the use of LDL-cholesterol concentration as a basis for defining those individuals who should be treated with lipidlowering agents.' The European Atherosclerosis Society recommended the estimation of LDLcholesterol (LDL-C) as a part oflaboratory diagnosis of patients with severe and, particularly, combined hyperlipidaemia." Separation of the lipid subfractions by ultracentrifugation is expensive and time consuming, and is confined to specialist laboratories. Consequently, many centres rely on the computation of the LDLcholesterol levels using Friedewald's formula," This formula, however, becomes invalid as triglyceride levels exceed 4·5 mmol/L.
We adapted the ultracentrifugation method of lipoprotein sub fractionation as used by the Lipid Research Clinics Program (LRC)9 to the tabletop ultracentrifuge. In our view this provides a fast and convenient method of lipoprotein fractionation which could be adapted by specialized lipid clinics.
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MATERIALS AND METHODS
Blood sampling technique Samples of venous blood were taken after a 14h fast from the antecubital vein of randomly selected patients attending the Lipid Outpatient Clinic for routine investigations. Blood was transferred to EDTA containers and plasma was immediately separated by centrifugation (5000 g, 15min, Sorvall RT 6000 centrifuge. DuPont, Stevenage, UK). Plasma was stored at 4°C until analysis. The separation of lipoprotein subfractions was performed within 48 h of blood sampling except for the between batch imprecision study, where samples were stored for up to 6 days.
Measurement of cholesterol in plasma and in lipid subfractions
EDTA plasma was used throughout. Cholesterol was measured on a Cobas Bio analyser (Roche Diagnostics, Welwyn Garden City, UK) using an enzymatic method (CHaD-PAP, BCL, Lewes, UK) which was standarized using primary cholesterol standards (Reference Laboratory for Cholesterol Assays, Bilthoven, The Netherlands). The between batch coefficient of variation (CV) of the method was < 3%.
LRC method for the separation of lipid subfractions Lipoproteins were separated by ultracentrifugation according to the LRC procedure" using an LS-65 preparative ultracentrifuge (Beckman Instruments, High Wycombe, UK) and Ultrac1ear 13 x 64 mm centrifuge tubes (Beckman). Prior to ultracentrifugation plasma samples were overlayered with potassium bromide solution (Sigma Chemicals, Poole, UK) of density 1·006 gIL. The density of the solution was checked by refractometry (Digital Densitymeter DMA35, Paar Scientific Ltd, London). We used a fixed angle rotor (type T40·3) and the following running parameters: temperature 4°C, centrifugal force 142 000 g, centrifugation time 18 h and sample volume 5 mL. After centrifugation, the infranate (bottom fraction), containing LDL and high density lipoproteins (HDL), separated from the supernate (top fraction), containing very low density lipoproteins (VLDL), by tube slicing. Total cholesterol measurements were performed on plasma before separation and on both. supernate and infranate after ultracentrifugation. HDL-cholesterol (HDL-C) was measured in the infranate. LDL-C was calculated according to the formula: 
Separation of lipid subfractions using the tabletop ultracentrifuge
We adapted the LRC method to a TL-IOO tabletop system (Beckman Instruments) using a TL-IOO'3 rotor. Unless stated otherwise the running parameters were; temperature 4°C, centrifugal force 541 000 g, centrifugation time 2·5 h and sample volume 2 mL. Polyallomer Quick-Seal 13 x 32 mm centrifuge tubes (Beckman) were used throughout. Prior to centrifugation, the tubes were heat-sealed using a tube sealer (Beckman). After completion of centrifugation the samples were analysed as stated for the LRC method. Within-batch and between-batch imprecision studies were performed, but were limited to six specimens each.
In the within-batch experiment the number of samples was limited by the single rotor capacity. Duration of the between-batch experiment was limited to 6 days, as the storage of plasma even at 4°might affect the sedimentation behaviour of lipoprotein subtractions."
Other procedures
HDL-C was measured using heparin/manganese chloride as precipitant." The precipitate was separated by ultracentrifugation on the TL-IOO centifuge using TL-l ()(). 3 rotor (temperature 4°C, 143 200 g, 30 min) using 13 x 62 mm polycarbonate centrifuge tubes (Beckman). This step can also be performed using a high-speed refrigerated centrifuge." Completeness of separation of lipid subfractions was assessed by agarose gel electrophoresis (90 V, 50 min) of both infranate and supernate using agarose plates (Corning Medical, Palo Alto, USA) and Fat Red B stain (Sigma).
Statistical analysis
Statistical analysis was performed using nonparametric methods. The comparison of paired samples was performed using Wilcoxon rank test. Kendall (tau) correlation coefficients were used for the assessment of correlations. Linear regression was calculated using the least squares method and Deming's correction" was employed for method comparison studies. Unless otherwise stated, medians (ranges) are given throughout. We used STATGRAPHICS software."
RESULTS

Separation time
The time required for separation of VLDL into the supernatant was assessed by varying centrifugation time from 0·5 to 4·0 h. Complete separation was achieved within 2·5 h. At this time electrophoresis of the supernate showed a single band corresponding to VLDL and electrophoresis of the infra nate showed two bands corresonding to LDL and HDL, respectively ( Fig. I) . The sum of cholesterol concentrations in the supernate and infranate was compared to the concentration of total cholesterol in plasma on 45 samples taken from patients with plasma cholesterol concentrations ranging from 4·22 to 10·15 mmol/L. There was a mean 4·4% difference (P < 0'001) between the sum of cholesterol concentrations in both subfractions (6,98 mmol/L) and total cholesterol concentration (7·30mmol/L). The sum ofcholesterol concentrations in both fractions correlated with the total cholesterol concentration (r = 0,821, P < 0,001). In 41 of 45 patients (91'2%) the difference ranged from -0·22 to 0'74mmo1/L (median 0·23mmol/L). In the remaining four patients the differences were 0·98, 1,99, 1·47 and 2·30 mmol/L. These differences The accuracy of the calculation of VLDL-C concentration was investigated by comparison of the calculated VLDL-C concentration with the cholesterol content of the supernate on samples from 45 patients. The mean measured VLDL-C concentration (O'S4mmol/L) was lower than calculated VLDL-C (0'89mmol/L) (P < 0'001) and there were considerable differences between the two procedures, particularly on samples with high VLDL-C concentration (range of differences -0,98 to 2·3mmol/L). Calculated and measured VLDL-C concentrations showed poor correlation (r .. 0,516, P < 0'001).
Impreclllloa of tbe method
The imprecision of the procedure was studied using plasma samples with total cholesterol concentrations ranging from 3·86 to 11·36mmol/L ( Table I) . For the method using the TLiOO ultracentrifuge the within-batch coefficient of variation for VLDL-C estimation ranged from 15·6 to 29·8%. For LDL-C the within-batch CV varied between 2% and 6·9% and for HDL-C between 2·4% and 3·3%. Between-batch varia- tion was similar to within-batch variation. For the LRC method the within-batch precision was assessed using blood samples with total cholesterol concentration of 6·17 and 7·23 mrnol/L (n = 6 at each level). The CVs of VLDL-C estimation at mean concentrations of 0·38 and 0·76 mmol/L were 50% and 34,2%, respectively, the CVs of LDL-cholesterol measurements at 4·58 and 4·73 mmol/L were 4·8% and 4·9%, respectively, and the CVs of HDL-C measurements at mean concentrations of 1·09 and 1·74 mmol/L were 5·5% and 2,3%, respectively.
Comparison with the LRC procedure
We measured lipid subfractions on 79 patient samples using both the LRC method and the tabletop system. The range of plasma cholesterol concentrations studied was 3,2-11,33 mmol/L and that for plasma triglycerides 0·4-9,9 mmol/L.
We observed significant correlations between the measurement oflipid subfractions by the two methods for VLDL-C (r = 0'94, P < O'()()I), LDL-C (r = 0·98, P < 0,001) and HDL-C (r = 0,94, P < 0,001).
The mean VLDL-C concentrations obtained using the LRC procedure and the tabletop system were 0·70 (0'04-6,5) mmol/L and 0·99 (0'17-7'09) mmol/L, respectively (P < 0,01). LDL-C concentrations as measured by the LRC method and the tabletop system were 4·43 (1'68-,8,6) mmol/L and 4·37 (1'68-8'95) mmol/L, res-pectively. The difference is significant, P < O·()()1. HDL-C concentrations were 1·09 (0'21-1'98) mrnol/L and 1·09 (0'19-2'06) mmol/ L, respectively. The difference is significant P < 0·002.
DISCUSSION
The cholesterol present in plasma is distributed between the various lipoprotein subfractions. LDL is the major cholesterol-transporting lipoprotein. 12 Epidemiological studies have shown LDL-C concentrations to correlate with the incidence of CHD. It is now clear that the knowledge of LDL-cholesterol levels allows a more accurate classification of patients at risk of CHD than the measurement of total cholesterol as well as better identification of patients who require medical advice and/or lipid-lowering treatment.v"" An estimated 12% of individuals who appear to be at high risk of CHD on the basis of total cholesterol estimation appear to be normal on subsequent lipoprotein analysis," Lipid lowering drugs have variable effects on VLDL and LDL and the monitoring of changes in concentration of particular subfractions allows better targeting of drug therapy. ' Ultracentrifugation remains superior to other methods used to measure LDL-C. However, this procedure is time-consuming and the capital cost of a full size ultracentrifuge is high. Furthermore, the relatively high volume of blood required for this analysis makes it inconvenient for patients who need to be frequently monitored.
The measurement of LDL-C by precipitation methods has been shown to have poor precision at clinically significant levels (LDL-C above 4·0 mmol/L). These methods are also non-specific in the presence of elevated levels of VLDL-C. The coefficient of variation ofLDL measurement using polyvinyl sulphate or heparin as precipitant was reported. as 5% at LDL-C concentrations above 4·0 mrnol/L and increased further with rising concentrations of LDL_C. 13 Consequently, the most common method of the assessment of LDL-C concentration is calculation using the Friedewald formula." This calculation derives LDL-C from total plasma cholesterol, HDL-C and plasma triglyceride concentrations. The calculation involves the multiplication of plasma triglyceride by a factor which is an estimate of the cholesterol content of the VLDL. However, the ratio of triglyceride to cholesterol in VLDL is known to be variable. The use of several different factors has been proposed." Furthermore, the use of both the Friedewald formula and precipitation methods is restricted to patients with plasma triglyceride levels below 4·5 mmol/L. In our Lipid Clinic 15% of patients have triglyceride concentrations greater than 4·5 mmol/L (unpublished data). These methods are also not applicable to patients with type III hyperlipidaemia due to the increased ratio of cholesterol to triglyceride in their VLDL. 13 The method employed by the LRC involves also calculation of LDL-C and VLDL-C, but these computations involve simple subtractions rather than the use of empirical factors.
Our adaptation of the ultracentrifugation method to the tabletop system allows the analysis of lipid subfractions on volumes of blood smaller than those required for the reference method (2 mL vs 5 mL). The CV of the LDL-C estimation improved with increasing concentration (3'8% at a concentration of 4·3 mmol/L, 2·0% at 9-4 mmol/L). No precision data for the LRC method were quoted in the original source," but Okazaki et al. l s who investigated the precision of sequential flotation ultracentrifugation found the CV of LDL measurements to be 3·27% and that of VLDL to be 3·85%. However, these authors measured choline-containing phospholipids rather than total cholesterol as a marker of concentration of different lipoprotein subfractions.
The calculation of VLDL-C concentration rather than direct measurement of VLDL-C was recommended for the LRC method, as it is recognized that the recovery of the ultracentrifugal top fraction can be difficult." In our study, difficulties with recovery of the top fraction were the most probable cause of occassionally observed large differences between total cholesterol concentration in plasma and the sum of the cholesterol contents of infranate and supernate. At the same time the imprecision of total cholesterol measurement, as well as that of LDL-C and HDL-C estimations was low. The accuracy of our cholesterol measurement was ensured by the use of serum-based cholesterol standards. The calculated value of VLDL-cholesterol includes the errors of the total cholesterol measurement, measurement of cholesterol in the subfractions and the error involved in the recovery of top fraction. This is further compounded by the fact that normally the VLDL concentration is low and close to the detection limit of the cholesterol method. Our results suggest that in the small volume method on a TLI 00 ultracentrifuge the measurement of top fraction cholesterol content is not reliable and we confirm the recommendation of the LRC programme to use calculated VLDL values. The 29·3% difference in median values for VLDL-C observed between the LRC method and our procedure, in absolute terms involves a difference in cholesterol levels of approximately 0·2 mmol/L, In our view this does not compromise the clinical value of the results obtained, as therapeutic manoeuvres are unlikely to be considered in patients with total triglyceride levels below 3 mmol/L, which represents a two-to three-fold increase of VLDL-C compared to normal levels." The concentrations of LDL-C and HDL-C obtained using the TL-IOO tabletop system correlated well with those obtained using the LRC method. Although the results obtained using the two methods were significantly different, the mean difference was only 1·0% for LDL-C and 1·75% for HDL-C. Our procedure is faster than that of the LRC due to the shorter centrifugation time employed. The tabletop system is considerably less expensive both in terms of capital and revenue costs compared to a method which requires the use of a full size preparative ultracentrifuge.
Our method could provide a convenient alternative to the LRC method for laboratories which provide a service to specialized lipid clinics.
